{
  "article": {
    "id": "",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11998595/",
    "title": "The Last Mile in Beta-Cell Replacement Therapy for Type 1 Diabetes: Time to Grow Up",
    "authors": [
      "Lorenzo Piemonti"
    ],
    "journal": "",
    "year": "",
    "keywords": [
      "diabetes type 1",
      "beta cell replacement therapy",
      "islet",
      "scalability",
      "stem cell derived beta cells"
    ],
    "funding": [],
    "abstract": "Beta cell replacement therapy for type 1 diabetes (T1D) is undergoing a transformative shift, driven by advances in stem cell biology, gene editing, and tissue engineering.",
    "sections": {
      "introduction": "",
      "methods": "",
      "results": "",
      "discussion": ""
    },
    "experimental_factors": {
      "organism": "mouse",
      "organism_raw": "mouse",
      "cell_type": "",
      "cell_type_raw": "",
      "tissue": "",
      "tissue_raw": "",
      "tissue_list": [],
      "tissue_detail": [],
      "treatment": "",
      "treatment_raw": "",
      "treatment_list": [],
      "treatment_detail": [],
      "duration": "",
      "duration_raw": "",
      "sex": "",
      "sex_raw": "",
      "sex_list": [],
      "genotype": "",
      "genotype_raw": "",
      "genotype_detail": {
        "text": "",
        "normalized": ""
      },
      "strain": "",
      "strain_raw": "",
      "line_name": "",
      "line_name_raw": "",
      "model_type": "",
      "model_type_raw": "",
      "age_at_sampling": "",
      "age_at_sampling_detail": {
        "raw": "",
        "normalized": "",
        "range": {
          "min": "",
          "max": ""
        }
      },
      "duration_detail": {
        "raw": "",
        "normalized": "",
        "range": {
          "min": "",
          "max": ""
        }
      },
      "cell_type_detail": {
        "text": "",
        "normalized": "",
        "ontology": {
          "id": "",
          "label": ""
        }
      }
    },
    "technologies": [],
    "technologies_detail": [],
    "insights_summary": "Translating breakthroughs in beta cell replacement therapy into scalable, widely accessible treatments poses significant challenges. A Quality by Design approach is proposed to bridge the “last mile” and make beta cell therapy a viable, widely accessible treatment.",
    "acknowledgments": "The authors wish to express their sincere gratitude to SOStegno 70 Insieme ai ragazzi diabetici Associazione Onlus (Project “Beta is better”), as well as Paola Macchieraldo, Antonio Mincione, Luca Casaura, Patrizia Pappini Oldrati, Paolo Bignoli, Andrea Marchesi, and Michele Mainardi for their support of the fundraising campaign “Un brutto t1po,” which helps sustain research on beta cell replacement at the San Raffaele Diabetes Research Institute in Milan.",
    "references": []
  }
}